Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
“David’s extensive experience building, leading and financing biopharmaceutical companies will add significant value to Novavax’ board, especially now as we laser-focus on contributing to some of the world’s most daunting healthcare challenges,” said
“I am delighted to join the Board of Directors of
Statements herein relating to the future of
Source: Novavax, Inc.